PALISADE BIO, INC. — Director's Dealing 2015

Nov 20, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuralstem, Inc. (CUR)
CIK: 0001357459
Period of Report: 2015-11-19

Reporting Person: OLDAKER WILLIAM CLYDE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-19	Common Stock	M	15000	$0.00	Acquired	196826	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-19	Restricted Stock Unit	$	M	15000	Disposed		Common Stock (15000)	Direct

Footnotes

F1: Represents the conversion of restricted stock units into Common Stock. On November 19, 2015, the reporting person was granted 15,000 shares of Common Stock upon conversion.

F2: Each restricted stock unit represents a right to receive one share of Neuralstem's Common Stock.